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Abstract
Aquaporin membrane protein channels mediate cellular water flow. Human aquaporin 5
(AQP5) is highly expressed in the respiratory system and secretory glands where it facili-
tates the osmotically-driven generation of pulmonary secretions, saliva, sweat and tears.
Dysfunctional trafficking of AQP5 has been implicated in several human disease states,
including Sjögren’s syndrome, bronchitis and cystic fibrosis. In order to investigate how the
plasma membrane expression levels of AQP5 are regulated, we studied real-time translo-
cation of GFP-tagged AQP5 in HEK293 cells. We show that AQP5 plasma membrane
abundance in transfected HEK293 cells is rapidly and reversibly regulated by at least three
independent mechanisms involving phosphorylation at Ser156, protein kinase A activity
and extracellular tonicity. The crystal structure of a Ser156 phosphomimetic mutant indi-
cates that its involvement in regulating AQP5 membrane abundance is not mediated by a
conformational change of the carboxy-terminus. We suggest that together these pathways
regulate cellular water flow.
Introduction
The flux of water across biological membranes is facilitated by transmembrane protein chan-
nels called aquaporins (AQPs). AQPs passively transport water in response to osmotic gradi-
ents, while excluding the movement of ions and protons [1] and thus are important for cell
volume regulation [2]. In humans, thirteen members of the AQP family (AQP0-12), with sub-
tle functional differences, are expressed with different tissue-specific and time-dependent pro-
files [3].
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Eukaryotes have evolved to fine-tune water transport through AQPs by three main regula-
tory mechanisms: (i) at the transcriptional/translational level; (ii) by conformational change or
“gating” and (iii) by translocation to the membrane in response to a trigger. Regulation by
AQP gene expression and/or AQP protein degradation can be achieved over a timescale from
hours to days. However, this does not account for the dynamic control of AQPs that may be
necessary to rapidly alter membrane water permeability in response to environmental or cellu-
lar signals. Instead, this can be achieved by gating; a conformational change of the AQP protein
that alters the permeability of the pore. In addition, translocation can regulate the number of
AQP molecules present in the target membrane, altering membrane water permeability by
changing the number of pores present.
Structures of gated AQPs have revealed the molecular details of AQP gating by phosphory-
lation, pH and Ca2+ for the spinach aquaporin SoPIP2;1 [4] and mechanosensitivity for the
yeast aquaporin AQY1 [5]. Furthermore, mammalian AQP0 is suggested to be gated in a pH
and Ca2+-dependent manner, the latter being mediated by an interaction with calmodulin, as
described by a recent structural model [6]. While gating of other mammalian AQPs remains to
be conclusively shown, translocation is a common regulatory mechanism. The best-character-
ised example of this type of regulation is that of human AQP2 in the kidney: AQP2 abundance
in the apical membrane is dependent on vasopressin-activated phosphorylation of a carboxy-
terminal serine residue (Ser 256) by cAMP-dependent protein kinase A (PKA) [7]. Phosphory-
lation in response to a hormonal trigger has also been shown to mediate membrane transloca-
tion of AQP1 [8], AQP5 [9–11] and AQP8 [12], on a timescale of minutes to hours.
Translocation in response to an osmotic stimulus has been demonstrated to regulate AQP1
activity on a timescale of seconds; exposure to hypotonic conditions resulted in rapid recruit-
ment to the cell surface via a mechanism dependent on transient receptor potential channels,
extracellular calcium influx, calmodulin, and the phosphorylation of two threonine residues
(Thr 157 and Thr 239) of AQP1 [13].
AQP5 is found in tissues such as the lungs, airways and secretory glands and consequently
plays a major role in the generation of saliva, tears and pulmonary secretions [14–16]. AQP5
dysregulation has been implicated in several disease states, including bronchitis, cystic fibrosis
[17] and Sjögren’s syndrome [18]. AQP5 translocation has been shown to be affected by cAMP
in a PKA-dependent manner, with exposure to elevated intracellular cAMP levels causing a
short-term (minutes) decrease in AQP5 membrane abundance whereas long-term (8 hours)
exposure increased total AQP5 protein [15]. There are two consensus PKA sites in AQP5: Ser
156 in cytoplasmic loop D [19, 20] and Thr 259 [10] in the carboxy-terminus; the latter corre-
sponds to Ser 256 in AQP2. AQP5 can be directly phosphorylated by PKA at Ser 156 and Thr
259 [21]. Notably, Ser 156 was phosphorylated preferentially in certain tumors suggesting that
cell proliferation can be modulated by phosphorylation of this site although the constitutive
membrane abundance of an S156A mutant was not distinguishable from wild-type AQP5 [22].
Based on the crystal structure of human AQP5 it was hypothesized that phosphorylation of Ser
156 could cause structural changes in loop D that would break its interaction with the carboxy-
terminus, thereby flagging the protein for translocation to the plasma membrane [23].
In order to investigate the role of Ser 156 in the membrane translocation of AQP5, we used
real time translocation studies in living HEK293 cells; GFP-tagged full-length AQP5 mutants
were designed to either abolish or mimic phosphorylation of Ser 156. Our data show that the
phosphomimetic mutation of Ser 156 to glutamate (S156E) increased constitutive membrane
expression of AQP5. Inhibition of PKA increased constitutive membrane expression of wild-
type, S156E and S156A, suggesting that the effect of PKA on AQP5 translocation is not solely
dependent Ser 156. We further show rapid membrane translocation upon a hypotonic stimulus
independently of both Ser 156 phosphorylation and PKA activity. Finally, we have used x-ray
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crystallography to show that the phosphomimetic S156E mutation does not cause any signifi-
cant structural changes to the protein as previously suggested. We propose that three indepen-
dent mechanisms regulate the membrane abundance of AQP5, one of which involves
phosphorylation of Ser 156.
Materials and Methods
Cloning of AQP5-GFP fusion constructs for analysis in HEK293 cells
Human full-length AQP5 was fused with carboxy-terminal GFP using the Invitrogen Gateway™
cloning system according to the instructions provided by the supplier. For directional cloning
of blunt-ended PCR products into an entry vector using the Gateway™ system, four bases
(GGGG) were added to the 50-end of the forward primer followed by the 25bp attB1 attach-
ment sequence (underlined, below). This was followed by five bases (bold) to introduce a
Kozak sequence upstream and to keep the sequence in frame with the AQP coding sequence.
Finally 18-25bp of the AQP5 sequence were added to create the amino-terminal forward prim-
ers, 50-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCC ACC ATG–AQP5(18-25bp)-
30. For the reverse primer, four bases (GGGG) were added to the 50-end followed by the 25bp
attB2 attachment sequence (underlined) and then one base (bold) was added to keep the
sequence in frame with the AQP5 coding sequence. Finally 18-25bp of the AQP sequence with-
out the stop codon were added to create the carboxy-terminal forward primers 50-GGG GAC
CAC TTT GTA CAA GAA AGC TGG GTC–AQP5(18-25bp)-30. KOD polymerase was used
in PCR amplification of the AQP cDNA. Samples were heated to 94°C for 2 min, followed by
30 cycles of 94°C for 30 s, 55°C for 30 s and 68°C for 3 min and then 68°C for 7 min. Purified
PCR products were sub-cloned into the pDONR221™ entry vector (Invitrogen) using the attB1
and attB2 sites in a reaction with Gateway™ BP Clonase™ enzyme mix (Invitrogen).
pDONR221™ vectors containing the required sequences were recombined with the pcDNA-D-
EST47 Gateway™ vector using the attL and attR reaction with Gateway™ LR Clonase™ enzyme
mix (Invitrogen). This created expression vectors with the cycle 3 mutant of the GFP gene at
the carboxy-terminus of the AQP gene of interest, which were subsequently expressed as fusion
proteins. The mutant constructs S156E and S156A were amplified using the well-established,
modified QuikChange procedure (Stratagene), as previously described [13] and according to
their manual. All plasmids were handled and purified using standard molecular biological
procedures.
Cell culture and transfection
HEK 293 cells were routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum in humidified 5% (v/v) CO2 in air at 37°C. Cells
were seeded into 30 mm Fluorodish™ dishes and transfected after 24 h at 50% confluence using
the Transfast (Promega) transfection protocol with 2 μg of DNA/dish. PKA inhibition was
achieved by incubation with 3.6 μMmyristoylated PKI 14–22 amide (Enzo Life Sciences, Exe-
ter UK) for 30 minutes.
Confocal microscopy
AQP5-GFP fusion proteins were visualized in live cells enclosed in a full environmental cham-
ber by confocal laser scanning microscopy. Confocal images were acquired 24 h post-transfec-
tion with a Leica SP5 or Zeiss 780 laser scanning microscope using a 63× (1.2 NA) water
immersion objective. Images were acquired using an argon laser (excitation 488 nm; emission
band pass 505–530 nm) for GFP, UV excitation and a He-Ne laser (excitation 543nm; emission
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filter long pass (LP) 650 nm). Cells were visualized in control medium (DMEM) that had an
inorganic salt concentration of 120 mM, a glucose concentration of 25 mM and an osmolality
in the range 322–374 mosM/kg H2O. Hypotonic medium has an osmolality in the range 107–
125 mosM/kg H2O through dilution of DMEM by a factor of 3 with water.
Determination of sub-cellular localization
Protein localization was measured using a line profile (pixel density) traced on each transfected
cell. Localization data are representative of three to five cells from at least three independent
experiments. Line expression profiles were generated and analyzed with the program ImageJ
(http://rsb.info.nih.gov/ij/) and are indicated in yellow and displayed beside each confocal
image. A minimum of five line profiles were measured, distributed at regular intervals covering
the plasma membrane and the cytosol, but avoiding the nucleus of a minimum of three cells
from at least three independent experiments The fluorescence intensity over this distance was
also measured and the difference between the peak and the plateau of fluorescence was divided
by the maximum fluorescence along the line scan to calculate the percentage of fluorescence at
the membrane. This was termed the relative membrane expression (RME) [24, 25]. The overlay
of the GFP image with the bright-field image indicated integration of GFP-tagged AQP5 at the
plasma membrane as well as in the cytoplasm of HEK293 cells. In addition, correct membrane
insertion of AQP5-GFP and both S156 mutants was suggested by colocalization with the fluo-
rescent plasma membrane marker FM 4–64 as previously described for AQP4-GFP..
RME values were compared by one way ANOVA followed by either paired (for images of
the same cell before and after treatment) on unpaired (for images of different cells under differ-
ent conditions) post-hoc t-tests. The p values from the post-hoc tests were multiplied by the
number of pairwise comparisons (Bonferroni correction); p< 0.05 after correction was consid-
ered statistically significant.
Cloning of hAQP5 S156E for structural analysis
A single mutation of Ser 156 to glutamate was introduced into a vector encoding wild-type
human AQP5 using the QuikChange1 Site-Directed Mutagenesis Kit (Stratagene) according
to their protocol. In addition, a construct was made in which the carboxy-terminus was trun-
cated by introducing a stop codon after Pro 245. All mutations were confirmed by sequencing
and the construct was subsequently used to transform Pichia pastoris X-33 cells. High yielding
transformants were selected based on growth on high Zeocin concentrations as described pre-
viously [25].
Protein production and purification
Clones were grown in 3L fermentors with glycerol and methanol feed phases. Harvested cells
were resuspended in breaking buffer (50 mM phosphate buffer pH7.5, 5% glycerol) and broken
by three passages through an X-press cell (Biox AB). Cell debris was pelleted by centrifugation
at 10,000 × g for 30minutes. This centrifugation step was repeated to ensure that all debris had
been removed. Membranes were collected at 200,000 × g for 90 minutes, washed in urea buffer
(4M urea, 5 mM Tris, 2 mM EDTA 2 mM EGTA) and NaOH (20 mM) and finally resus-
pended in 7 ml resuspension buffer (20 mMHepes pH7.8, 50 mMNaCl, 10% glycerol, 2 mM
β-MeOH) per gram of membrane.
Membranes were solubilized in resuspension buffer with 6% n-nonyl-β-D-glucoside for 1h
at room temperature. Unsolubilized material was removed by centrifugation at 186,000g for
30min. The supernatant was diluted with dilution buffer (20 mMMES pH6.0, 10% glycerol,
0.4% NG and 2 mM β-MeOH) and purified using a Resource S column (GE Healthcare, 20
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mMMES pH6.0, 0.4% NG and 15 mM-1M NaCl) followed by gel filtration on Superdex 200
column (GE Healthcare, 20 mM Tris-HCl pH7.5, 100 mMNaCl, 0.4% NG). Fractions contain-
ing hAQP5 S156E was concentrated in a 10,000 MWCO concentrator (Vivaspin) to a final
concentration of 7–13 mg/ml.
Crystallization
Crystallization experiments were set up at 8°C using the hanging drop vapor diffusion tech-
nique. 7.2 μl reservoir solution (100 mM Tris-HCl pH7.8 or 7.9, 100 mM NaCl, 21% PEG400)
was mixed with 1.8 μl each of 1,6-hexanediol (30%, v/v) and 1,3-propanediol (40%, v/v) and
mixed with the protein in a 1:1 ratio. Crystals were obtained within 5–7 days and were fished
and flash frozen in liquid nitrogen without any addition of cryoprotectant.
Data collection and structure determination of AQP5 S156E
Complete X-ray diffraction data were collected on frozen crystals at cryo temperature (100
K) at the European Synchrotron Radiation Facility (ESRF) beamline ID23-2. Crystals of full-
length AQP5 S156E diffracted to 3.5 Å and belonged to space group P312 with one tetramer
in the asymmetric unit. Cell dimensions were a = b = 174.3, c = 100.9 Å, A = B = 90°, γ =
120°. Crystals of truncated AQP5 S156E crystals diffracted to 2.6Å and belonged to the space
group P63 with two tetramers in the asymmetric unit. Cell dimensions were a = b = 171 Å,
c = 171, 190 Å, A = B = γ = 90°. Images were processed and scaled using iMosflm and Scala
from the CCP4 suite [26]. The structures was solved using molecular replacement using Pha-
ser [27] with the wild-type hAQP5 structure (PDB code 3D9S [23]) as a model. Further
refinement of full-length and truncated AQP5 S156E was done in Refmac5 [28] and Phenix
[29] respectively, with iterative manual rebuilding in Coot [30]. The quality of the structure
was checked using MolProbity included in Phenix. The current model of full length AQP5
S156S contains 4 chains (A-D) with the following amino acids: A 2–245, B 5–247, C 4–245
and D 2–254. A-D as well as one phosphatidylserine. The current model of truncated
hAQP5-S156E contains 8 chains A-H with amino acids 2–245, one phosphatidyl serine and
690 waters. The two structures refined to an Rwork and Rfree of 28.0 and 31.1% for full length
AQP5 S156E and 18.7% and 23.0% for truncated AQP5 S156E. For crystallographic statistics,
see Table 1.
Results
A phosphomimetic mutation at Ser 156 increases constitutive AQP5
surface abundance
An expression vector was made in which GFP was fused to the carboxy-terminus of full-length
human AQP5 (AQP5-GFP). This expression vector was used to transfect live HEK293 cells.
Real-time localization and translocation of the corresponding fusion protein was measured
using confocal microscopy; the relative membrane expression (RME) was determined using
line intensity profiles generated from confocal images of individual live cells. An RME of 0 cor-
responds to an equal distribution of GFP signal between membrane and intracellular compart-
ments and an RME of 1 corresponds to 100% of the GFP signal at the membrane. The RME of
AQP5-GFP was increased by the introduction of the S156E mutation from 0.56 ± 0.02 to
0.67 ± 0.01 (p = 0.01), whereas the RME of AQP5-S156A was not significantly different
(p = 0.36) to wild-type AQP5-GFP (Fig 1).
Regulation of Human AQP5 Membrane Abundance
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PKA inhibition increases constitutive AQP5 surface abundance
The RME of AQP5-GFP (wild-type and the two S156 mutants) was measured after a 30 minute
incubation with a cell-permeable PKA inhibitory peptide (myrPKI) or vehicle control. PKA
inhibition increased the RME of all AQP5 constructs (Fig 2) compared to non-inhibited con-
trols, suggesting a role for PKA signalling in the internalization of AQP5 as previously sug-
gested [15]. PKA inhibition further increased the membrane abundance of the S156E mutant,
indicating that this effect is independent of the phosphorylation status of Ser 156.
Hypotonicity-induced AQP5 translocation is independent of PKA activity
and phosphorylation at S156
Reduction of the extracellular osmolality to 85 mOsm/kg H2O caused rapid relocalization of
AQP5 from intracellular compartments to the plasma membrane (Fig 3). The initial
AQP5-GFP distribution profile was restored on returning to normal physiological osmolality.
The RME of AQP5-GFP increased from 0.56 ± 0.03 in control medium to 0.72 ± 0.01 in hypo-
tonic medium. This result was similar to that seen for AQP1, which translocated to and from
Table 1. Crystallographic data and refinement statistics for full-length and truncated hAQP5 S156E
structures.
Full length Truncated
Data collection
Beamline ESRF ID23-2 ESRF ID23-2
Wavelength (Å) 0.8726 0.8726
Detector distance (mm) 413 306.6
Oscillation/collection range (°) 1/100 0.4 (92)
Resolutiona (Å) 101.02–3.5 (3.69-3-5) 50.81–2.60 (2.74–2.60)
Total observationsa 142,487 (20,652) 375,143 (54,612)
Unique reﬂectionsa 21,914 (3,193) 94,885 (13,925)
Completenessa 98.9 (99.8) 98.8 (99.4)
Redundancya 6.5 (6.5) 4.0 (3.9)
I/σa 13 (1.9) 7.0 (2.1)
Rsym
a,b (%) 0.095 (0.799) 0.180 (0.778)
Reﬁnement
Resolutiona (Å) 100–3.5 48.2–2.60
Space group (α, β, γ) P312 (90, 90, 120) P63 (90, 90, 120)
Cell dimensions (a, b, c) 174, 174, 101 171, 171, 190
Molecules in the asymmetric unit 4 8
Rwork
c/Rfree
d (%) 28.0/31.1 18.7/23.0
Average B valules, entire model (Å2) 161.6 31.4
Average B values, protein/waters (Å2) 163.4/- 31.1/35.6
Root-mean-square deviations from ideal values
Bond lengths (Å) 0.007 0.008
Bond angles (°) 1.084 1.058
PDB accession code 5DYE 5C5X
a Values in brackets are for the highest resolution shell
b Rsym = ΣhΣi|Ii(h)-<I(h)>|/ ΣhΣiI(h), where Ii(h) is the ith measurement.
c Rwork = Σh||F(h)obs|-|F(h)calc||/Σh|F(h)obs|
d Rfree was calculated for 5% of reﬂections randomly excluded from the reﬁnement
doi:10.1371/journal.pone.0143027.t001
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the membrane in response to altered tonicity in the surrounding media [24]. Similarly, the
RME increased from 0.55 ± 0.02 to 0.71 ± 0.02 for the S156A mutant and from 0.67 ± 0.02 to
0.81 ± 0.01 for the S156E mutant. Despite an increased level of constitutive surface expression,
the change in RME for the S156E mutant (ΔRME = 0.14 ± 0.01) was similar to that for AQP5
or the S156A mutant (ΔRME = 0.15 ± 0.03 and 0.13 ± 0.02 respectively). Inhibition of PKA,
despite increasing constitutive surface expression of all constructs, did not inhibit the hypoto-
nicity-induced relocalization of AQP5. Taken together, these results suggest that hypotonicity-
Fig 1. Surface expression of AQP5 S156mutants.Representative fluorescence confocal micrographs of
HEK293 cells transfected with GFP-tagged (A) AQP5 wild-type, (B) AQP5-S156A and (C) AQP5-S156E; the
fluorescence intensity profiles along each yellow line are shown. (D) Relative membrane expression
calculated from fluorescence intensity profiles: 5 profiles were taken per cell and at least 3 cells per
micrograph, repeated in 3 independent experiments. Asterisks denote p < 0.05 using Student’s t-test followed
by Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g001
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induced relocalization of AQP5 is not mediated by either PKA activity or phosphorylation at
Ser 156.
The crystal structure of AQP5 S156E suggests phosphorylation is not
accompanied by a conformational change
We previously solved the structure of wild-type human AQP5 expressed in P. pastoris to 2.0 Å
resolution [23]. To determine whether phosphorylation of Ser 156 confers any structural
changes that could be important for membrane translocation, we crystallized and solved the
Fig 2. Effect of PKA inhibition on surface expression of AQP5.Representative fluorescence confocal
micrographs of HEK293 cells transfected with GFP-tagged (A) AQP5 wild-type, (B) AQP5-S156A and (C)
AQP5-S156E that were treated with a PKA inhibitory peptide for 30 minutes. (D) Relative membrane
expression of the 3 AQP5 constructs with and without PKA inhibition. Asterisks denote p < 0.05 using
Student’s t-test followed by Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g002
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structure of a single phosphomimetic mutant (S156E) of full-length AQP5 at 3.5 Å resolution
(PDB code 5DYE). Since at this resolution, information about side-chain positions and interac-
tions is limited, we truncated AQP5 S156E at Pro 245, the last visible residue in the high-reso-
lution wild-type structure AQP5. The truncated AQP5 S156E construct crystallized in a
different space group and diffracted to significantly higher resolution, allowing us to solve the
structure at 2.6 Å resolution (PDB code 5CX6). Both full-length and truncated AQP5 S156E
crystallized in space groups lacking the four-fold symmetry otherwise commonly associated
with AQP crystals (P312 with one tetramer in the asymmetric unit for full-length AQP5 S156E
and P63 with two tetramers in the asymmetric unit for truncated AQP5 S156E), thereby allow-
ing for structural differences between monomers in the tetramer to be examined. Crystallo-
graphic data and refinement statistics are summarized in Table 1.
Both structures of AQP5 S156E are very similar to that of wild-type AQP5; overlaying with
a root-mean-square deviation of 0.51 Å for 970 Cα-atoms for full-length AQP5 S156E and of
0.37Å for 975 Cα-atoms for truncated AQP5 S156E (Fig 4A & 4B). For full-length AQP5
S156E, additional electron density could be seen beyond Pro 245 in one of the monomers
(monomer D), allowing us to build nine more residues (Fig 4C). However, this region does not
interact with any other residues within the tetramer. Instead, it forms crystal contacts with
symmetry-related AQP5 molecules in the crystal packing, explaining why this region is ordered
in this particular monomer of the full-length structure.
In the truncated AQP5 S156E structure, seven water molecules were observed in the water-
conducting channel of all monomers with one exception, monomer F, which contained six
water molecules. For full-length AQP5 S156E, the limited resolution prevented the identifica-
tion of water molecules in the channel. In both structures, a lipid molecule could be observed
Fig 3. Hypotonicity-induced translocation of AQP5.Relative membrane expression of AQP5 and mutants
was measured in the same cells before and 1 minute after reduction of the extracellular osmolality to 85
mOsm/kg H2O by fourfold dilution of the culture medium with dH2O. PKA inhibition was achieved by a 30
minute incubation with a PKA inhibitory peptide. Asterisks denote p < 0.05 by paired t-tests followed by
Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g003
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in the central channel formed between monomers in the tetramer, albeit at slightly different
positions. Similarly to wild-type AQP5, this lipid was modelled as phosphatidyl serine
(Fig 4D).
Loop D and the carboxy-terminus retain their native conformations in
AQP5 S156E
In the wild-type AQP5 structure, an interaction between loop D and the carboxy-terminal
region was observed [23]. This interaction anchored at the carboxy-terminal helix in a manner
that was well conserved in other mammalian AQP structures and involved hydrogen bonds
between the sidechain of Arg 153 and the backbone atoms of Pro 226 and Phe 227 (Fig 5A). It
Fig 4. Overall structure of AQP5 S156E. (A) The structure of full length (green, PDB code 4DYE) and truncated S156E AQP5 (orange, PDB code 5CX6)
overlaid on the wild-type structure of AQP5 in blue (PDB code 3D9S). Water molecules in the water-conducting channel of truncated S156E AQP5 are shown
as red spheres. (B) Same as in (A), viewed from the cytoplasmic side. (C) Structure of the carboxy-terminus of full-length S156E monomer D, showing its
interactions with a symmetry-related molecule (grey). 2Fobs-Fcalc electron density is displayed at 1.0 σ. Loop D and Glu 156 in monomers A and D are
highlighted in yellow. (D) Lipid molecule in the tetrameric channel of full-length and truncated AQP5 S156E.
doi:10.1371/journal.pone.0143027.g004
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was hypothesized that phosphorylation of Ser 156 may cause structural changes within loop D
that breaks these interactions, allowing for a conformational change of the carboxy-terminus.
Since there were no significant differences between the strucutres of full-length and trun-
cated AQP5 S156E, we used the higher-resolution truncated AQP5 S156E structure to examine
the finer structural details (from hereon denoted as AQP5 S156E). No structural change of
loop D was observed in any of the eight monomers when compared to wild-type hAQP5 (Fig
5B) and the interactions between loop D and the carboxy-terminus were conserved (Fig 5A).
The carboxy-terminus retained the same conformation as in the wild-type AQP5 structure (Fig
5C). In two of the monomers in each tetramer, there was a 1–2 Å shift in the position of the
small carboxy-terminal helix when compared to wild-type AQP5. Comparison between the 8
monomers of AQP5 S156E shows that the carboxy-terminal helices overlap perfectly, suggest-
ing that the shift in position arises from minor structural differences between monomers in
wild-type AQP5. As is apparent from the electron density map in Fig 5D, serine was success-
fully replaced by glutamate at position 156.
Fig 5. Structure of loop D and its interaction with the carboxy-terminus.Wild-type AQP5 and AQP5
S156E are coloured blue and orange respectively. (A) Zoomed in view of the boxed area in Fig 4A showing
that the interactions between loop D and the carboxy-terminus are maintained in the S156E mutant structure.
Hydrogen bonds are shown as dashed lines. Structural comparison of (B) loop D and (C) the carboxy-
terminus shows that there are no structural differences between wild-type AQP5 and AQP5 S156E. In (D),
the four monomers from the crystal structure of human AQP2 are overlaid, showing a significant
conformational variability of the carboxy-terminal helix within the tetramer. The four AQP2 monomers are
colored in different shades of grey. (D) Structure of the S156E mutation site showing 2Fobs-Fcalc electron
density contoured at 1.0 σ. The structure of wild-type AQP5 is shown in blue for comparison.
doi:10.1371/journal.pone.0143027.g005
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Discussion
The regulation of protein abundance in a particular membrane requires a delicate balance
between two opposing processes: Translocation to and internalization from the membrane.
This is achieved through multiple sorting signals, often consisting of post-translational modifi-
cations in the cytoplasmic regions of the protein. One of the best-characterized examples is
AQP2, for which phosphorylation of multiple sites in the carboxy-terminus governs its translo-
cation to the apical membrane [31]. Internalization of AQP2 is triggered by ubiquitination of
the carboxy-terminus [32] and the internalization rate is also influenced by the phosphoryla-
tion status of AQP2 in the membrane [33].
Emerging evidence suggests that the regulation of AQP5 cell surface abundance is equally
complex. It is known that AQP5 translocation between intracellular storage vesicles and the
apical membrane can occur upon agonist stimulation of the muscarinic (M3) receptor [34] or
α-1 adrenergic receptor [35]. Furthermore, intracellular cAMP levels have been shown to reg-
ulate AQP5 abundance at the transcriptional level as well as affect the long-term ( 24 hours)
sub-cellular distribution of the protein in a PKA-dependent manner [11]. Interestingly,
increased cAMP levels have been shown to have a biphasic effect on the sub-cellular distribu-
tion of AQP5 with decreased expression in the apical membrane in the short term due to
increased internalization, followed by an increase in membrane abundance in the long-term
[15]. While inhibition of PKA had an effect on both components of this biphasic response, an
increase in levels of phosphorylated AQP5 could only be seen for the long-term effect, sug-
gesting that the target for PKA-phosphorylation in the short-term response is not AQP5
itself. This dual response to increased levels of cAMP on the trafficking of AQP5 could help
explain why increased as well decreased expression in the apical membrane have been
reported [14, 16].
AQP5 contains two consensus PKA-sites but unlike AQP2, their roles in AQP5 transloca-
tion have not been determined. PKA-mediated phosphorylation of AQP5 has been demon-
strated at both Ser 156 [21] and Thr 259 [36]. However, removal of these phosphorylation sites
by mutation to alanine resulted in constructs with the same membrane abundance as wild-type
AQP5. Additional phosphorylation sites are predicted to be present in AQP5, for example a
PKC site at Ser 152 that overlaps with the PKA site at Ser 156. Furthermore, Thr 259 is also
part of a PKG consensus site. These are additional components that may affect the overall
translocation of AQP5 in a cell-dependent manner.
Our data suggest that membrane-localization of AQP5 is regulated by at least three inde-
pendent pathways (Fig 6). We show that membrane expression of AQP5 is affected by phos-
phorylation of Ser 156, either by increased targeting or decreased internalization or both. To
our knowledge this is the first time a phosphorylation site has been directly linked to a differ-
ence in membrane expression. The fact that the S156A mutant behaves like wild-type AQP5
indicates that phosphorylation of Ser 156 may not occur under basal conditions. In this respect
it is intriguing that Ser 156 has been shown to be preferentially phosphorylated in tumour cells
[21]. It has been suggested that in tumours, PKA-dependent phosphorylation of Ser 156
increases cell proliferation by activating the Ras-pathway [37]. A number of studies have
shown that upregulation of AQPs promotes cell proliferation and migration [38] Our data hint
at a mechanism whereby phosphorylation of Ser 156 in AQP5 increases its membrane localiza-
tion, thereby enhancing cancer cell proliferation.
It was previously suggested that phosphorylation of Ser156 would break interactions
between loop D and the carboxy-terminus, thereby triggering a conformational change [23].
Significant conformational variability of the carboxy-terminus was seen in the structure of
human AQP2, where the carboxy-terminal helix of each monomer adopted a unique
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conformation that had not been observed in any previous mammalian AQP structure (Fig 5C)
[39]. As the carboxy-terminal region is known to be important for membrane translocation of
both AQP2 [31] and AQP5 [10, 40], such conformational changes may be recognized as a
structural sorting signal by the cellular trafficking machinery. However, our structure of the
AQP5 S156E mutant did not reveal any structural differences within loop D or the carboxy-ter-
minus (Fig 5B and 5C). We therefore suggest that it is the presence of a phosphate group at Ser
156 rather than a conformational change of the carboxy-terminus that is recognized as a sort-
ing signal, resulting in increased AQP5 membrane abundance.
Our data further show that, independent of Ser 156, basal levels of PKA activity (i.e. in the
absence of a cAMP-stimulating agonist) decrease the membrane abundance of AQP5 (Fig 2).
This fits well with the short-term effect of cAMP and PKA that has been seen previously and
for which PKA has been suggested to be involved in AQP5 internalization [15]. Since PKA-
inhibition further increased membrane expression of the S156E mutant, this indicates that
phosphorylation of Ser 156 is not responsible for this short-term effect. Instead, we suggest
that Ser 156 phosphorylation may be involved in the long-term cAMP and PKA-dependent
effect whereby an increase in AQP5 membrane abundance is seen after several hours. This is in
agreement with the observation that the long-term effect of cAMP and PKA involves direct
phosphorylation of AQP5 while the short-term effect does not [15].
Finally, we show that AQP5-GFP is rapidly translocated to the target membrane of HEK293
cells in response to hypotonic conditions, but that this translocation is independent of Ser 156
in loop D and also independent of PKA (Fig 3).
Fig 6. A proposedmodel of the equilibrium between vesicular and surface-localized AQP5. Panel A shows wild-type AQP5 under isotonic conditions.
The large arrows represent an increase in AQP5 translocation (and the small arrows are a decrease). This is regulated by three independent factors:
Phosphorylation of AQP5 at position S156 (orange cylinders in panel B; shown by a phosphomimetic glutamate substitution (S156E) of AQP5; the effect of
PKA (green cylinders in panel C) and the effect of decreasing the relative tonicity of the environment (panel D). We speculate that these three pathways
control the surface abundance of AQP5.
doi:10.1371/journal.pone.0143027.g006
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The hypotonicity-induced membrane translocation of AQP5 described here is consistent
with that of AQP1 where the phosphorylation of Thr157 and/or Thr239 by PKC results in
rapid accumulation in the cell-surface membrane [13]. Whether direct phosphorylation of
AQP5 by PKC or another kinase mediates hypotonicity-induced membrane translocation in a
similar manner remains to be shown. AQP5 is found in tissues that are subject to rapid changes
in osmolarity and has been shown to play an important role in cell volume regulation [14–16].
Upon exposure to hypotonic conditions, cells undergo a rapid cellular volume decrease (RVD)
to avoid rupture. This happens within a couple of minutes and involves the release of cellular
water. RVD is often followed by a regulatory volume increase (RVI) whereby the osmotically
shrunken cell approaches its original volume [2]. The rapid response to hypotonicity reported
here supports the involvement of AQP5 in RVD as previously suggested [14]. On a longer time
scale, hypotonic exposure has been shown to cause a decrease in AQP5 membrane abundance
[16], most likely corresponding to the RVI response. Taken together, regulation of AQP5
membrane abundance seems to be important for both the RVD and RVI components of cell
volume regulation.
We previously showed that hypotonicity-induced calcium influx through TRPC1 was vital
for translocation of AQP1 [13] and others have shown that calcium influx through TRPV4
mediates the AQP5-dependent regulatory volume decrease in acinar cells [14]. We therefore
speculate that the sensor of extracellular osmolality that leads to AQP5 translocation is a mem-
ber of the TRP family of gated cation channels.
Conclusion
Due to its importance for fluid secretion in airways submucosal glands, AQP5 has been sug-
gested to be a pharmacological target to treat the hyper-viscous and excessive gland secretions
in cystic fibrosis and bronchitis/rhinitis, respectively. Our data provide the first link between a
specific AQP5 phosphorylation site, Ser 156, and changes in its sub-cellular localization. We
further show that the Ser 156-mediated change in localization does not require a substantial
protein conformational change. We show that, independent of Ser 156, PKA is further involved
in basal recycling of AQP5 between the plasma membrane and intracellular compartments.
Finally, we provide evidence of tonicity-regulated changes in AQP5 localization that are not
mediated by phosphorylation of Ser 156 or PKA. This will now enable us to elucidate the
detailed mechanism by which these post-translational modifications govern translocation of
the protein from intracellular storage vesicles to the target membrane in response to protein
kinase activity and osmotic triggers, thus providing key information for drug design targeting
AQP5.
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